BHCM
PRCT icon

Brevan Howard Capital Management’s Procept Biorobotics PRCT Stock Holding History

Brevan Howard Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Buy
48,239
+20,357
+73% +$574K 0.01% 816
2025
Q4 		$877K Buy
27,882
+16,746
+150% +$555K 0.01% 826
2025
Q3 		$397K Buy
11,136
+4,074
+58% +$186K ﹤0.01% 1404
2025
Q2 		$407K Buy
+7,062
New +$399K ﹤0.01% 1437
2025
Q1 		– Sell
-28,849
Closed -$2.32M – 1394
2024
Q4 		$2.32M Buy
28,849
+22,094
+327% +$1.89M 0.01% 266
2024
Q3 		$541K Buy
+6,755
New +$480K ﹤0.01% 659

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brevan Howard Capital Management's PRCT Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Procept Biorobotics (PRCT) stake by 73% in Q1 2026, buying an estimated $574K and bringing the position to 48,239 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #816.

Brevan Howard Capital Management first reported a position in PRCT in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.32M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Brevan Howard Capital Management held 48,239 shares of Procept Biorobotics worth $1.21M as of Q1 2026.
  • Brevan Howard Capital Management bought 20,357 Procept Biorobotics shares in Q1 2026, an estimated $574K.
  • Procept Biorobotics made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #816 holding.
  • Brevan Howard Capital Management first reported a position in Procept Biorobotics in Q3 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Procept Biorobotics position peaked at $2.32M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.